Pentamer List | ProImmune

Introduction to Pentamers

Pentamer Handbook

Custom Pro5® Pentamers

Pentamer Applications

Technical Webcasts about Pro5® Pentamers

Customer Testimonials

Pentamer Publications

Pentamer Case Studies

Request Quote

Catalog Pro5® MHC Class I Pentamers

Pentamers by Research Area

Adenovirus HCV Malaria SIV
Autoimmunity HIV miHAg Trypanosoma
Cancer HPV Model Antigen Tuberculosis
Chlamydia HTLV Negative Vaccinia
CMV Influenza Other VSV
EBV LCMV RSV West Nile Virus
HBV Listeria Sendai Virus Yellow Fever

 

Adenovirus
Publications citing Adenovirus Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*01:01
686
TDLGQNLLY
A
Adenovirus 5 Hexon 886-894
A*24:02
684
TYFSLNNKF
A
Adenovirus 5 Hexon 37-45
B*07:02
989
KPYSGTAYNAL
A
Adenovirus Hexon 114-124

 

Autoimmunity
Publications citing AutoImmunity Pentamers
Case studies of Customer Research into AutoImmunity

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
151
KLQVFLIVL
A
T1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13
A*02:01
954
LNIDLLWSV
A
T1D Diabetes IGRP 228–236
A*02:01
851
HLVEALYLV
A
Insulin B chain 10-18
A*02:01
393
VMNILLQYV
A
GAD65 114-122
A*02:01
470
SLSRFSWGA
A
Myelin basic protein 110-118
A*02:01
1904
VLFGLGFAI
A
T1D Diabetes IGRP 265-273

(back to top)

 

Cancer
Publications Citing Cancer Pentamers
Case Studies of Customer Research into Cancer

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*01:01
307
KSDICTDEY
A
Tyrosinase 243-251 (244S)
A*02:01
2291
AILALLPAL
A
Prostate Stem Cell Antigen (PSCA) 105-133
A*02:01
1920
ALLTSRLRFI
A
Telomerase Reverse Transcriptase (hTRT) 615-624
A*02:01
2083
FLAEDALNTV
A
Epithelial Discoidin Domain Receptor 1 (EDDR1) 867-876
A*02:01
2079
FLYDDNQRV
A
Topoisomerase II-alpha-b 828-836
A*02:01
1386
GLAPPQHLIRV
A
p53 187-197
A*02:01
468
ILSLELMKL
A
Receptor for hyaluronic acid–mediated
motility (RHAMM) 165-173
A*02:01
1464
LTLGEFLKL
A
Survivin-3A 96-104
A*02:01
2299
SLPPPGTRV
A
p53 149-157
A*02:01
1403
VIMPCSWWV
A
Chondromodulin-I 319-327
A*02:01
1201
YMCSFLFNL
A
Ewing Tumor EZH2 666-674
A*02:01
061
YMDGTMSQV
A
Tyrosinase 369-377 (371D)
A*02:01
447
YLQVNSLQTV
A
Telomerase Reverse Transcriptase (hTRT) 988-997
A*02:01
859
KLQDASAEV
A
HM1.24-aa 126-134
A*02:01
329
ILLWQPIPV
A
Prostatic Acid Phosphatase-3 (PAP-3) 135-143
A*02:01
560
GLMEEMSAL
A
Human Mena protein (overexpressed in breast cancer)
A*02:01
813
FVGEFFTDV
A
GPC3 144-152 (overexpressed in hepatocellular carcinoma)
A*02:01
075
YLSGANLNL
S
Carcinogenic Embryonic Antigen (CEA) 571-579
A*02:01
157
VLYRYGSFSV
A
gp100 (pmel17) 476-485
A*02:01
250
VLQELNVTV
S
Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177
A*02:01
097
VISNDVCAQV
A
Prostate Specific Antigen-1 (PSA-1) 154-163
A*02:01
390
SLLMWITQV
A
NY-ESO-1 157-165
A*02:01
212
RLLQETELV
S
HER-2/neu 689-697
A*02:01
810
LIAHNQVRQV
A
HER-2/neu 85–94
A*02:01
690
LLHETDSAV
A
PSMA/PSM-P1 4-12
A*02:01
599
ALDVYNGLL
A
Prostatic acid phosphatase precursor (PAP) 299-307
A*02:01
645
YLNTVQPTCV
A
EGF-R 1138-1147
A*02:01
781
VLDGLDVLL
A
PRAME 100-108
A*02:01
689
VLAGGFFLL
A
PSMA 27-38
A*02:01
394
YLFFYRKSV
A
mTERT 572-580
A*02:01
034
FLWGPRALV
A
MAGEA3 271-279
A*02:01
646
KLFGTSGQKT
A
EGF-R-479 350-359
A*02:01
915
TLPGYPPHV
A
PAX-5 311-319
A*02:01
1056
SLFLGILSV
A
CD20 188-196 (B cell malignancies)
A*02:01
117
RLVDDFLLV
A
Telomerase Reverse Transcriptase 865-873
A*02:01
208
LLLLTVLTV
A
MUC-1 12-20
A*02:01
205
LLGRNSFEV
A
p53 264-272
A*02:01
600
ALFDIESKV
A
PSM P2 (prostate)
A*02:01
1013
FLGYLILGV
A
Prostatic Acid Phosphatase-3 (PAP-3)
A*02:01
561
TMNGSKSPV
A
hMena 502-510
A*02:01
391
LMLGEFLKL
S
Survivin 96-104
A*02:01
338
QLCPICRAPV
A
Livin/ML-IAP280 175-184
A*02:01
1181
SLSEKTVLL
A
CD59 glycoprotein precursor 106-114
A*02:01
958
SLVDVMPWL
A
Cytochrome p450 1B1 239-248
A*02:01
214
KIFGSLAFL
A
HER-2/neu 369-377
A*02:01
046
IMDQVPFSV
S
gp100 (pmel17) 209-217
A*02:01
210
ILHNGAYSL
A
HER-2/neu 435-443
A*02:01
085
ILAKFLHWL
S
Telomerase 540-548
A*02:01
249
HLSTAFARV
A
G250 (renal cell carcinoma) 217-225
A*02:01
125
GVLVGVALI
A
Carcinogenic Embryonic Antigen (CEA) 694-702
A*02:01
527
ALYVDSLFFL
A
PRAME PRA 300–309
A*02:01
405
KLQCVDLHV
A
Prostate Specific Antigen 146-154
A*02:01
086
ALQPGTALL
A
Prostate Stem Cell Antigen (PSCA) 14-22
A*02:01
302
KVAELVHFL
A
MAGEA3 112-120
A*02:01
057
KTWGQYWQV
A
gp100 (pmel17) 154-162
A*02:01
389
GLYDGMEHL
A
MAGEA-10 254-262
A*02:01
404
FLTPKKLQCV
A
Prostate Specific Antigen-1 (PSA-1) 141-150
A*02:01
082
ELAGIGILTV
s
MelanA / MART 26-35
A*02:01
171
KVLEYVIKV
A
MAGEA1 278-286
A*02:01
2293
GLQHWVPEL
A
BA46 (Lactadherin) 97-106
A*02:01
2294
GVRGRVEEI
A
bcr-abl fusion protein
A*02:01
048
YLSGADLNL
A
Carcinoembryonic antigen (CEA)-derived peptide CAP1-6D
A*02:01
2296
ITDQVPFSV
A
gp100 (pmel) 209-217
A*02:01
047
YLEPGPVTV
A
gp100 (pmel) 280-288 (288V)
A*02:01
2301
YLQLVFGIEV
A
MAGEA2 157-166
A*02:01
2298
KVAEELVHFL
A
MAGEA3 112-120 (alternative version)
A*02:01
049
SLLMWITQC
A
NY-ESO-1 157-165 (9C)
A*02:01
2300
YLGSYGFRL
A
p53 103-111
A*02:01
2297
KLCPVQLWV
A
p53 139-147
A*02:01
654
RMPEAAPPV
A
p53 65-73
A*02:01
1787
RLTSRVKAL
A
Telomerare Reverse Transcriptase (hTRT) 653-661
A*02:01
1786
GLLGASVLGL
A
Telomerase Reverse Transcriptase (hTRT) 674-683
A*02:01
381
LLLTVLTVV
A
Tumor Mucin Antigen 13-21
A*03:01
118
ALLAVGATK
A
gp100 (pmel17) 17-25
A*03:01
264
ATGFKQSSK
A
bcr-abl 210 kD fusion protein 259-269
A*03:01
087
KQSSKALQR
S
bcr-abl 210 kD fusion protein 21-29
A*03:01
541
RISTFKNWPK
A
Survivin-3A 18-27 (27K)
A*24:02
416
EYLQLVFGI
A
MAGEA2 156-164
A*24:02
421
TFPDLESEF
A
MAGEA3 97-105
A*24:02
209
TYACFVSNL
A
Carcinogenic Embryonic Antigen (CEA) 652-660
A*24:02
417
TYLPTNASL
A
HER-2/neu 63-71
A*24:02
418
VYGFVRACL
A
Telomerase reverse transcriptase (hTRT) 461-469
A*24:02
230
AFLPWHRLF
A
Tyrosinase 188-196
A*24:02
2303
CYASGWGSI
A
Prostate Specific Antigen-1 153-161
A*24:02
238
VYFFLPDHL
A
gp100-intron 4 170-178
A*24:02
1806
RYCNLEGPPI
A
Lymphocyte antigen 6 complex locus K (LY6K) 177-186
A*24:02
2302
AYACNTSTL
A
Survivin 80-88
B*07:02
2304
LPWHRLFLL
A
Tyrosinase 208-216
B*08:01
094
GFKQSSKAL
A
bcr-abl 210 kD fusion protein 19-27
B*35:01
2307
MPFATPMEA
A
NY-ESO-1 94-102
H-2 Db
1731
ATFKNWPFL
A
Murine Survivin 20-28
H-2Db
695
Abu-Abu-L-Abu-LTVFL
A
Moloney murine sarcoma virus (MoMSV) GagL 85–93
H-2Db
2199
FSNSTNDILI
A
VEGFR2/KDR fragment 1 614-624
H-2Db
1333
KVPRNQDWL
A
gp100 (pmel17) 25-33
H-2Kb
185
SVYDFFVWL
A
Tyrosinase related protein-2 180-188
H-2Kb
351
HNTQYCNL
A
MAGEA5 5-12
H-2Kb
2311
TVSEFLKL
A
Murine Survivin 97-104
H-2Kd
0275
DYWGQGTEL
A
Surface IgG (sA20-Ig) of A20 106-114
H-2Kd
814
EYILSLEEL
A
GPC3 298-306
H-2Kd
343
TYVPANASL
A
neu/HER-2/Erbb2 proto-oncoprotein 66-74
H-2Ld
150
LPYLGWLVF
A
Tumour Antigen P815 35-43

(back to top)

 

Chlamydia

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01  
334
RLNMFTPYI
A
Chlamydia trachomatis MOMP 258-266

(back to top)

 

CMV
Publications citing CMV Pentamers

Case Studies of Customer Research into CMV

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*01:01
739
VTEHDTLLY
A
HCMV pp50 245-253
A*01:01
266
YSEHPTFTSQY
A
HCMV pp65 363-373
A*02:01
1598
VLAELVKQI
A
HCMV IE1 81-89
A*02:01
008
NLVPMVATV
S
HCMV pp65 495-504
A*03:01
1599
KLGGALQAK
A
HCMV IE1 184-192
A*24:02
414
QYDPVAALF
A
HCMV pp65 341-349
A*24:02
380
VYALPLKML
A
HCMV pp65 113-121
B*07:02
045
TPRVTGGGAM
S
HCMV pp65 417-426
B*07:02
308
RPHERNGFTVL
A
HCMV pp65 265-275
B*08:01
691
QIKVRVDMV
A
HCMV IE1 88-96
B*35:01
114
IPSINVHHY
A
HCMV pp65 123-131
H-2Db
2313
HGIRNASFI
A
MCMV m45 985-993
H-2Dd
278
AGPPRYSRI
A
MCMV m164 257-265
H-2Ld
021
YPHFMPTNL
S
MCMV IE1 168-176

(back to top)

 

EBV
Publications citing EBV Pentamers
Case Studies of Customer Research into EBV

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
666
FLYALALLL
A
EBV LMP-2 356-364
A*02:01
001
GLCTLVAML
S
EBV BMLF-1 259-267
A*02:01
042
CLGGLLTMV
S
EBV LMP-2 426-434
A*02:01
409
YLLEMLWRL
A
EBV LMP-1 125-133
A*02:01
2292
FLDKGTYTL
A
EBV BALF-4 276–284
A*03:01
727
RLRAEAQVK
A
ENV EBNA 3A 603–611
A*11:01
639
ATIGTAMYK
A
EBV BRLF1 134-142
A*11:01
199
IVTDFSVIK
A
EBV EBNA-4 416-424
A*11:01
508
SSCSSCPLSK
A
EBV LMP-2 340-349
A*24:02
648
PYLFWLAAI
A
EBV LMP2 131-139
A*24:02
683
TYGPVFMSL
A
EBV LMP2 419–427
A*24:02
420
TYGPVFMCL
A
EBV LMP-2 419-427
B*07:02
044
RPPIFIRRL
S
EBV EBNA-3A 247-255
B*07:02
2305
QPRAPIRPI
A
EBV EBNA-3C 881-889
B*08:01
190
RAKFKQLL
S
EBV BZLF-1 190-197
B*08:01
073
FLRGRAYGL
S
EBV EBNA-3A 193-201
B*08:01
489
QAKWRLQTL
A
EBV EBNA3A 158-166
B*35:01
399
EPLPQGQLTAY
A
EBV BZLF-1 54-64
B*40:01
692
IEDPPFNSL
A
EBV LMP2 200-208

(back to top)

 

HBV
Publications citing HBV Pentamers
Case Studies of Customer Research into Hepatitis

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
032
FLLSLGIHL
S
HBV polymerase 573-581
A*02:01
027
FLLTRILTI
S
HBV envelope 183-191
A*02:01
023
FLPSDFFPSV
S
HBV core antigen 18-27
A*02:01
028
GLSPTVWLSV
A
HBV surface antigen 185-194
A*02:01
031
WLSLLVPFV
S
HBV surface antigen 172-181
A*02:01
283
FLPSDFFPSI
A
HBV core 18-27 (subtype ADR4)
A*11:01
377
YVNVNMGLK
A
HBV core antigen 88-96
A*24:02
413
KYTSFPWLL
A
HBV polymerase 756-764
A*24:02
378
EYLVSFGVW
A
HBV core 117-125
H-2Kb
422
ILSPFLPLL
A
HBV surface antigen 208-216
H-2Kb
1431
MGLKFRQL
A
HBV core 93-100
H-2Kb
477
VWLSVIWM
A
HBV Surface antigen 190-197
H-2Ld
129
IPQSLDSWWTSL
S
HBV surface antigen 28-39

(back to top)

 

HCV
Publications citing HCV Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*01:01
1066
ATDALMTGF
A
HCV NS3 1436-1444
A*01:01
740
ATDALMTGY
A
HCV NS3 1435-1443
A*02:01
036
VLSDFKTWL
A
HCV NS5a 1987-1995
A*02:01
172
LLFNILGGWV
A
HCV NS4b 1807-1816
A*02:01
242
KLSGLGINAV
A
HCV NS3 1406-1415
A*02:01
1094
GLQDCTMLV
A
HCV NS5B 2727-2735
A*02:01
003
CINGVCWTV
A
HCV NS3 1073-1081
A*02:01
004
YLLPRRGPRL
A
HCV core 35-44
A*02:01
002
DLMGYIPAV
S
HCV core 132-140
A*02:01
491
DLMGYIPLV
A
HCV core 132-140
A*02:01
040
KLVALGINAV
A
HCV NS3 1406-1415
A*02:01
858
CVNGVCWTV
A
HCV NS3 1073-1081
A*02:01
037
ALYDVVTKL
A
HCV NS5b 2594-2602
A*03:01
035
RVCEKMALY
A
HCV NS5B 2588-2596
A*24:02
415
AYSQQTRGL
A
HCV NS3 1031-1039
B*07:02
845
DPRRRSRNL
A
HCV core 111-119
B*07:02
742
GPRLGVRAT
A
HCV core 41-49
B*08:01
721
HSKKKCDEL
A
HCV NS3 1395-1403
B*35:01
565
HPNIEEVAL
A
HCV NS3 1359-1367
B*35:01
942
CPNSSIVY
A
HCV E1 207-214
B*40:01
939
REISVPAEIL
A
HCV NS5a 2266-2275
H-2Db
791
GAVQNEVTL
A
HCV NS3 1629-1637

(back to top)

 

HIV
Publications citing HIV Pentamers
Case Studies of Customer Research into HIV

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
430
GLADQLIHL
A
HIV-1 Vif 101-109
A*02:01
799
LTFGWCFKL
A
HIV-1 Nef 137-145
A*02:01
084
ILKEPVHGV
S
HIV-1 RT 476-484
A*02:01
246
KLTPLCVTL
A
HIV-1 env gp120 90-98
A*02:01
010
SLYNTVATL
S
HIV-1 gag p17 76-84
A*02:01
174
TLNAWVKVV
A
HIV-1 gag p24 19-27
A*03:01
194
RLRPGGKKK
S
HIV-1 gag p17 19-27
A*03:01
109
QVPLRPMTYK
S
HIV-1 nef 73-82
A*24:02
419
RYLKDQQLL
A
HIV-1 gag gp41 67-75
A*24:02
411
RYPLTFGWCY
A
HIV-1 Nef 134-143
B*07:02
257
TPGPGVRYPL
S
HIV-1 nef 128-137
B*07:02
196
IPRRIRQGL
A
HIV-1 env gp120 848-856
B*07:02
877
GPGHKARVL
A
HIV gag p24 223–231
B*08:01
193
FLKEKGGL
S
HIV-1 nef 90-97
B*08:01
195
GEIYKRWII
A
HIV-1 gag p24 261-269
B*15:01
1072
RLRPGGKKKY
A
HIV-1 p17 20-29
B*27:05
294
KRWIILGLNK
A
HIV-1 gag p24 265-274
B*27:05
874
KRWIIMGLNK
A
HIV-1 gag p24 263-272
B*27:05
2306
GRAFVTIGK
A
HIV-1 gp100 103-111
B*35:01
255
NPDIVIYQY
A
HIV-1 RT 328-336
B*35:01
1211
VPLDEDFRKY
A
HIV-1 RT 273-282
B*40:01
840
KEKGGLEGL
A
HIV-1 Nef 92-100
H-2Dd
177
RGPGRAFVTI
A
HIV-1 IIIB gp120 318-327
H-2Dd
1684
IGPGRAFYA
A
HIV-1 US4 gp120 318-326
H-2Kd
176
AMQMLKETI
A
HIV-1 gag p24 199-207

(back to top)

 

HPV

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
095
YMLDLQPETT
S
HPV 16 E7 11-20
A*02:01
2312
MLDLQPETT
A
HPV 16 E7 12-20
A*03:01
2064
KLCLRFLSK
A
HPV 33 E6 64-72
B*07:02
2065
KPTLKEYVL
A
HPV 33 E7 5-13
H-2Db
502H
RAHYNIVTF
A
HPV 16 E7 49-57

(back to top)

 

HTLV
Publications citing HTLV Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
200
LLFGYPVYV
A
Human T-cell lymphotropic virus-1 Tax 11-19
A*02:01
2309
AVLDGLLSL
A
HTLV bZIP factor 42-50
A*24:02
1043
SFHSLHLLF
A
Human T-cell lymphotropic virus-1 Tax 301-309

(back to top)

 

Influenza
Publications citing Influenza Pentamers
Case Studies of Customer Research into Influenza

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*01:01
076
CTELKLSDY
A
Influenza A (PR8) NP 44-52
A*01:01
540
VSDGGPNLY
A
Influenza A PB1 591-599
A*02:01
007
GILGFVFTL
S
Influenza A MP 58-66
A*02:01
2295
ILGFVFTLTV
A
Influenza A MP 59-68
A*03:01
77
ILRGSVAHK
A
Influenza A (PR8) NP 265-274
A*11:01
1513
SIIPSGPLK
A
Influenza A MP 13-21
A*11:01
1720
RMVLASTTAK
A
Influenza A MP1 178-187
A*11:01
1722
KSMREEYRK
A
Influenza A MP2 70-78
B*07:02
1744
SPIVPSFDM
A
Influenza A NP 473-481
B*07:02
1743
QPEWFRNVL
A
Influenza A PB1 329-337
B*27:05
463
SRYWAIRTR
A
Influenza A NP 383-391
H-2Db
119
ASNENMETM
S
Influenza A (PR8) NP 366-374
H-2Db
009
ASNENMDAM
S
Influenza A (NT60) NP 366-374
H-2Db
120
SSLENFRAYV
A
Influenza A (PR8) Polymerase acidic protein 224-233
H-2Kd
098
TYQRTRALV
S
Influenza A (PR8) NP 147-155
H-2Kd
240
IYSTVASSL
A
Influenza A HA 533-541

(back to top)

 

LCMV
Publications citing LCMV Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
2308
ALPHIIDEV
A
LCMV envelope gp 10-18
A*02:01
2310
YLVSIFLHL
A
LCMV envelope gp 447-455
H-2Db
070
FQPQNGQFI
S
LCMV NP 396-404
H-2Db
069
KAVYNFATC
S
LCMV GP1 33-41
H-2Db
186
SGVENPGGYCL
A
LCMV GP 276-286
H-2 Kb
2076
ISHNFCNL
A
LCMV GP 118-125

(back to top)

 

Listeria
Publications citing Listeria Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

H-2Kd
178
GYKDGNEYI
A
Listeria monocytogenes Listeriolysin 91-99

(back to top)

 

Malaria
Publications citing Malaria Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
314
YLNKIQNSL
A
Plasmodium falciparum CSP 334-342
H-2Kd
771
YYIPHQSSL
A
Plasmodium falciparum Liver stage antigen 1671-1679
H-2Kd
376
SYIPSAEKI
A
Plasmodium berghei CSP 252-260

(back to top)

 

miHAg
Publications citing miHAg Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
581
RTLDKVLEV
A
miHAg HA-8
A*02:01
175
FIDSYICQV
A
miHAg H-Y (human SMCY) 311-319
A*02:01
473
VLHDDLLEA
A
miHAg HA-1 137-145
B*07:02
1113
SPSVDKARAEL
A
miHAg SMCY 1041-1051
H-2Db
328
KCSRNRQYL
A
miHAg SMCY 738-746
H-2Db
327
WMHHNMDLI
S
miHAg UTY 246-254

(back to top)

 

Model Antigen
Publications citing Model Antigen Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

H-2Kb
093
SIINFEKL
S
Ovalbumin 257-264
H-2Kb
908
KVVRFDKL
A
Ovalbumin (subdominant) 55-62
H-2Kb
562
LTFNYRNL
A
Histocompatibility antigen 60 39-46
H-2Kb
1803
SIYRYYGL
A
Synthetic variant of VSV Nucleoprotein 498–505
H-2Kd
198
HYLSTQSAL
A
Enhanced Green Fluorescent Protein (eGFP) 200-208
H-2Ld
074
TPHPARIGL
S
E. coli beta-galactosidase 876-884

(back to top)

 

Negative

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
N01
NEGATIVE
S
Negative Control

(back to top)

 

Other
Publications citing other Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
366
LMWYELSKI
A
KSHVF-8 gB.492-500
A*02:01
773
VLPLTVAEV
A
Mesothelin 530–538
A*02:01
1152
VLMIKALEL
A
Non muscle Myosin-9 741-749
A*02:01
353
RILGAVAKV
A
Vinculin 822-830
A*02:01
133
LLDVPTAAV
A
Interferon gamma inducible protein (GILT) 30 27-35
A*02:01
1153
QLFNHTMFI
A
Non-muscle Myosin 478-486
E*01:01
712
VMAPRTLIL
A
HLA-C leader sequence peptide
H-2Kb
188
SSIEFARL
A
HSV-1 gp B 498-505
H-2Kb
828
KSPWFTTL
A
MuLV env 622-629
H-2Kb
488
VVYDFLKL
A
SV40 T antigen 404-411
H-2Kd
062
RYLKNGKETL
A
HLA-Cw3 170-179
H-2Kd
458
KYNKANVFL
A
NRP-V7 superagonist peptide 8.3 Tg NOD mouse
H-2Ld
398
SPSYVYHQF
A
MuLV env gp70 423-431

(back to top)

 

RSV
Publications citing RSV Pentamers
Case Studies of Customer Research into Viral Diseases

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
801
KMLKEMGEV
A
RSV NP 137-145
H-2Kd
154
SYIGSINNI
A
RSV M2 82-90
H-2Kd
149
KYKNAVTEL
A
RSV A strain F protein 85-93

(back to top)

 

Sendai Virus

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

H-2Kb  
056
FAPGNYPAL
S
Sendai virus NP 324-332

(back to top)

 

SIV

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

Mamu-A*01  
1110
CTPYDINQM
A
SIV Gag 181-189
Mamu-A*02  
1111
YTSGPGIRY
A
SIV Nef 159-167
Mamu-A*02  
1112
GSENLKSLY
A
SIV Gag 71-79

(back to top)

 

Trypanosoma
Publications citing Trypanosoma Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

H-2Kb
964
VNHRFTLV
A
Trypanosoma cruzi ASP-2 553-560
H-2Kb
708
ANYNFTLV
A
Trypanosoma cruzi SP 536-543

(back to top)

 

Tuberculosis
Publications citing Tuberculosis Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
324
GLPVEYLQV
A
Mycobacterium bovis antigen 85-A 6-14
A*02:01
276
KLIANNTRV
A
Mycobacterium bovis antigen 85-A 200-208
H-2Db
547
AIQGNVTSI
A
Mycobacterium tuberculosis ESAT-6 17-25
H-2Kb
769
IMYNYPAML
A
Mycobacterium tuberculosisTB10.4 4-12
H-2Kb
764
IMYNYPAM
A
Mycobacterium tuberculosisTB10.4 4-11
H-2Ld
158
MPVGGQSSF
A
Mycobacterium tuberculosis Ag85A 70–78

(back to top)

 

Vaccinia Virus
Publications citing Vaccinia Pentamers

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
978
ILDDNLYKV
A
Vaccinia virus Copenhagen Protein G5 18-26
A*02:01
703
KVDDTFYYV
A
Vaccinia virus Host range protein 2 74-82
H-2Kb
733
TSYKFESV
A
Vaccinia virus WR epitope B8R 20-27

(back to top)

 

Vesicular Stomatitis Virus

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

H-2Kb
373
RGYVYQGL
A
VSV NP 52
H-2Ld
622
MPYLIDFGL
A
VSV N 275-283

(back to top)

 

West Nile Virus

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

A*02:01
1320
RLDDDGNFQL
A
West Nile Virus NY-99 polyprotein precursor (1452-1461)
A*02:01
1327
YTMDGEYRL
A
West Nile virus NY-99 polyprotein precursor 2023-2031
A*02:01
1322
ATWAENIQV
A
West Nile virus NY-99 polyprotein precursor 3390-3398
H-2Db
663
LGMSNRDFL
A
West Nile Virus polyprotein 294-302

(back to top)

 

Yellow Fever

ALLELE

PEPTIDE CODE

PEPTIDE SEQUENCE

Stock/
Available

EPITOPE ORIGIN

H-2Kb  
1182
ATLTYRML
A
Yellow Fever Virus 17D polyprotein 268-275

(back to top)